Amos has a PhD in microbiology and a MBA from Tel-Aviv University. Prior to Cellect, Amos Served as COO at Valin Technologies and as the CEO of Pam-Bio; two biotechnology companies developing biopharmaceutical drugs and biosimilars in the fields of metabolic diseases, autoimmune diseases and bleeding disorders. He has experience in biopharmaceutical drug development, from discovery to clinical stage; and in evaluation and tech transfer of projects from academy to industry. Overall, Amos has 20 years of experience in Management and leadership of projects and teams, 10 of them in the biotech industry.

Back >>